We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.14 | 0.09% | 148.72 | 149.73 | 148.45 | 149.38 | 7,333,732 | 00:03:46 |
From May 2019 to May 2024
The U.S. Food and Drug Administration had granted Breakthrough Therapy Designation for JNJ-61186372 to treat certain patients with non-small-cell lung cancer. "Janssen Says FDA Grants Breakthrough Therapy Designation to JNJ-6372 to Treat Lung Cancer," at 4:27 p.m. EDT, incorrectly reported that it was for the treatment of certain patients with small-cell lung cancer in the first paragraph.
(END) Dow Jones Newswires
March 10, 2020 18:36 ET (22:36 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
